QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 1h ago

105last 24h

3125last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1819 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: MRKSentiment:bullish neutral bearish show all (incl. clickbait)

Proactive174d agoneutral

Regeneron faces Wall Street downgrades after high-profile melanoma drug fails to beat Merck's Keytruda

The Wall Street Journal174d agobearish

Regeneron Melanoma Drug Trial Disappoints and Shares Slide

Reuters179d agoneutral

European shares lifted by miners and tech; Mideast in focus

MarketBeat179d agoneutral

Merck KGaA Q1 Earnings Call Highlights

The Wall Street Journal179d agoneutral

Health Care Roundup: Market Talk

The Wall Street Journal179d agobullish

Germany’s Merck KGaA Raises Guidance

Simply Wall St.181d agoneutral

Investors Can Find Comfort In Merck's (NYSE:MRK) Earnings Quality

GuruFocus.com184d agoneutral

Merck Faces Gardasil Trial After $8.9 Billion Sales Peak

Moby184d agoneutral

Codexis, Inc. Q1 2026 Earnings Call Summary

Healthcare Dive184d agoneutral

Federation of American Hospitals taps new government relations head

MarketBeat185d agoneutral

Codexis Q1 Earnings Call Highlights

Reuters188d agoneutral

Factbox-Global drugmakers rush to boost US presence as tariff threat looms

JNJ LLY MRK PFE